» Authors » Hima Patel

Hima Patel

Explore the profile of Hima Patel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 448
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Yuan L, Mishra R, Patel H, Alanazi S, Wei X, Ma Z, et al.
Cancers (Basel) . 2020 Jun; 12(6). PMID: 32585852
B-Rapidly Accelerated Fibrosarcoma (BRAF) mutations are found in about 50% of melanoma patients. Treatment with Food and Drug Administration (FDA)-approved BRAF and MAP/ERK kinase (MEK) inhibitors has improved progression free...
22.
Patel H, Yacoub N, Mishra R, White A, Long Y, Alanazi S, et al.
Cancers (Basel) . 2020 Feb; 12(2). PMID: 32092958
Melanoma is the most lethal form of skin cancer. Melanoma is usually curable with surgery if detected early, however, treatment options for patients with metastatic melanoma are limited and the...
23.
Kiani S, Kamioka N, Black G, Lu M, Lisko J, Rao B, et al.
JACC Cardiovasc Interv . 2019 Nov; 12(21):2133-2142. PMID: 31699374
Objectives: The aim of this study was to define risk factors and develop a predictive risk score for new pacemaker implantation (PMI) after transcatheter aortic valve replacement (TAVR). Background: TAVR...
24.
Tingey L, Chambers R, Goklish N, Larzelere F, Patel H, Lee A, et al.
Arch Sex Behav . 2019 Aug; 49(6):1979-1994. PMID: 31399926
This analysis explored predictors of responsiveness to the Respecting the Circle of Life (RCL) intervention, a sexual and reproductive health program for American Indian (AI) youth. Data were collected over...
25.
Yuan L, Mishra R, Patel H, Abdulsalam S, Greis K, Luisa Kadekaro A, et al.
J Cancer . 2018 Dec; 9(24):4665-4676. PMID: 30588251
BRAF mutations occur in about 50% of melanoma patients. FDA approved BRAF and MEK inhibitors have improved the prognosis of patients with BRAF mutations. However, all responders develop resistance typically...
26.
Mishra R, Patel H, Alanazi S, Yuan L, Garrett J
Oncol Rev . 2018 Jul; 12(1):355. PMID: 30057690
ERBB family members including epidermal growth factor receptor (EGFR) also known as HER1, ERBB2/HER2/Neu, ERBB3/HER3 and ERBB4/HER4 are aberrantly activated in multiple cancers and hence serve as drug targets and...
27.
Jadeja S, Mansuri M, Singh M, Patel H, Marfatia Y, Begum R
J Dermatol Sci . 2018 Feb; 90(2):112-122. PMID: 29395581
Background: Several studies have reported hyperhomocysteinemia in vitiligo patients, suggesting the potential role of elevated homocysteine levels in precipitating vitiligo. Objectives: We aimed to estimate homocysteine and vitamin B levels,...
28.
Lu S, Hartert T, Everard M, Giezek H, Nelsen L, Mehta A, et al.
Pediatr Pulmonol . 2016 May; 51(12):1382-1392. PMID: 27152482
Background: We sought to identify predictors of asthma development following severe early childhood RSV bronchiolitis. Different definitions of asthma were also compared. Methods: This longitudinal, observational study (N = 343)...
29.
Bailey W, Holder D, Patel H, Devlin P, Gonzalez R, Hamilton V, et al.
Toxicol Sci . 2012 Aug; 130(2):229-44. PMID: 22872058
Alanine aminotransferase (ALT) activity is the most frequently relied upon reference standard for monitoring liver injury in humans and nonclinical species. However, limitations of ALT include a lack of specificity...